The peripheral nerve is demonstrated as a reticular pattern in a transverse section at high-resolution ultrasonography (US). Its echogenicity is between that of tendon and muscle. High-resolution US applied to lesions of peripheral nerves yields impressive results in that the nerve is highly differentiated from surrounding soft tissue. In cases of trauma, high-resolution US can easily differentiate between a rupture of the nerve bundle and fibroblast infiltration that results in traumatic neuroma. In cases of inflammation or compressive syndrome, high-resolution US can easily demonstrate lesion location and cause. In the evaluation of abnormal masses, high-resolution US cannot clearly differentiate neurofibromas from schwannomas but it can clarify the relationship between tumor and neural trunk and help the clinician plan treatment strategies. The authors discuss the success that can be achieved with the application of high-resolution US in the evaluation of peripheral nerve lesions. © RSNA, 2003

The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some nonliver applications. The third edition of the contrast-enhanced ultrasound (CEUS) guidelines was the joint World Federation for Ultrasound in Medicine and Biology-European Federation of Societies for Ultrasound in Medicine and Biology (WFUMB-EFSUMB) venture in conjunction with other regional US societies such as Asian Federation of Societies for Ultrasound in Medicine and Biology, resulting in a simultaneous duplicate on liver CEUS in the official journals of both WFUMB and EFSUMB in 2013. However, no guidelines were described mainly for Sonazoid due to limited clinical experience only in Japan and Korea. The new proposed consensus statements and recommendations provide general advice on the use of Sonazoid and are intended to create standard protocols for the use and administration of Sonazoid in hepatic and pancreatobiliary applications in Asian patients and to improve patient management.

Radiofrequency ablation (RFA) is a thermal ablation technique widely used for the management of benign thyroid nodules. To date, five academic societies in various countries have reported clinical practice guidelines, opinion statements, or recommendations regarding the use of thyroid RFA. However, despite some similarities, there are also differences among the guidelines, and a consensus is required regarding safe and effective treatment in Asian countries. Therefore, a task force was organized by the guideline committee of the Asian Conference on Tumor Ablation with the goal of devising recommendations for the clinical use of thyroid RFA. The recommendations in this article are based on a comprehensive analysis of the current literature and the consensus opinion of the task force members.